Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;48(3):794-799.
doi: 10.1007/s00259-020-05043-y. Epub 2020 Sep 22.

Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE

Affiliations
Review

Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE

Jeeban P Das et al. Eur J Nucl Med Mol Imaging. 2021 Mar.

Abstract

Purpose: We reviewed the clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).

Methods: Following the World Health Organization's declaration of a global pandemic, our department policy recommended Q-only SPECT/CT for all patients undergoing nuclear medicine evaluation for suspected PE to reduce the risk of aerosolization of respiratory droplets. We performed a retrospective review of sequential patients admitted with COVID-19 imaged with Q-SPECT/CT between March 17, 2020, and June 30, 2020, at Memorial Sloan Kettering Cancer Center. We recorded patient demographics, clinical symptoms, Wells score (to stratify patients according to pre-test probability for PE prior to Q-SPECT/CT), and noted ancillary imaging findings on CT.

Results: Of the 33 patients imaged with Q-SPECT/CT, 6 patients (3 men, 3 women) had a laboratory confirmed diagnosis of COVID-19 (mean age, 55, ± 11.4 years, range 33-68). All patients had a current diagnosis of malignancy and had a moderate or high pre-test probability for PE (mean Wells score 2.8, range 2-4). Q-SPECT/CT was positive in 4/6 (67%) of patients. Distribution of pulmonary emboli was bilateral and segmental in 75% of patients. Ancillary acute findings on SPECT/CT included bilateral parenchymal ground glass opacities (n = 5), pleural effusions (n = 2), and pneumomediastinum (n = 1).

Conclusion: Q-SPECT/CT has clinical utility for diagnosing PE in patients with COVID-19 where there is a contraindication for iodinated contrast media and a moderate or high pre-test probability for PE.

Keywords: COVID-19; Coagulopathy; Pulmonary embolism; V/Q SPECT/CT.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flowchart showing the patients included in our final analysis
Fig. 2
Fig. 2
Axial fused perfusion SPECT and CT (a) and axial perfusion SPECT (b) demonstrating a left upper lobe wedge-shaped defect (arrows) suspicious for pulmonary embolism. Axial CT chest images showing ancillary findings of pneumomediastinum (arrow) (c) and bibasal subpleural airspace disease (arrows) (d) suspicious for COVID-19 pneumonia
Fig. 3
Fig. 3
Axial fused Q-SPECT/CT (a) and SPECT (b) showing a left upper lobe wedge-shaped defect (arrows) suspicious for pulmonary embolism. An additional right lower lobe wedge-shaped defect was also seen (not shown). Axial CT chest images (c, d) showing small bilateral pleural effusion and bibasilar GGOs suspicious for COVID-19 pneumonia

Comment in

References

    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan , China : a retrospective cohort study. Lancet. 2020;673(6):1–9. - PMC - PubMed
    1. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication. J Thorac Imaging 2020.35:219–227. - PMC - PubMed
    1. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation. 2020;142:184–186. doi: 10.1161/CIRCULATIONAHA.120.047430. - DOI - PubMed
    1. Kaminetzky M, Moore W, Fansiwala K, Babb JS, Kaminetzky D, Horwitz LI. Pulmonary embolism on CTPA in COVID-19 patients. Radiol Cardiothoracic Imag. 2020;2.4:e200308. doi: 10.1148/ryct.2020200308. - DOI - PMC - PubMed
    1. Konstantinides SV, Torbicki A, Agnelli G, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–3069k. doi: 10.1093/eurheartj/ehu243. - DOI - PubMed